HAVRIX Rx

Select the drug indication to add to your list

HAVRIX

Vaccines
Only 4 drugs may be compared at once

Generic Name and Formulations:

Hepatitis A vaccine, inactivated 720 ELISA Units (EL.U.) per 0.5mL (pediatric), or 1440 EL.U. per 1mL (adult); susp for IM inj; aluminum adsorbed; contains neomycin (trace); preservative-free.

Company:

GlaxoSmithKline

Select therapeutic use:

Indications for HAVRIX:

Hepatitis A immunization.

Adult:

Inject into deltoid, preferably at least 2 weeks before expected exposure. >18yrs: 1440 EL.U. once IM; give booster dose 6–12 months after initial course.

Children:

Inject IM preferably at least 2 weeks before expected exposure. <12months: not recommended. 12months–18yrs: 720 EL.U. once IM; give booster dose 6–12months after initial course.

Contraindications:

Neomycin allergy. Previous hypersensitivity reaction to hepatitis A-containing vaccine.

Warnings/Precautions:

Have epinephrine (1:1000) inj available. Fever. Bleeding disorders. Immunodeficiency (may have suboptimal response). If given with immune globulin, use separate syringe and different site. Latex allergy. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Immunosuppressives may reduce efficacy. Concomitant vaccines: see literature.

Adverse Reactions:

Inj site reactions, headache, fatigue, fever, malaise, anorexia, GI upset.

How Supplied:

Single-dose vials—10; Single-dose prefilled Tip-Lok syringes—5 (without needles)

HAVRIX 1ml of 1440 elu/ml syringes (Qty:1)

appx. price $76.00